Showing results (51-60 of 87) with videos related to
Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|December 31, 2025
Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer modelsJulia Minnee, Wallace Zh Wong, Benjamin S Russell, et al.Biorxiv : the Preprint Server for Biology|July 27, 2021
Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 VariantsTakuya Tada, Hao Zhou, Marie I Samanovic, et al.Biorxiv : the Preprint Server for Biology|November 11, 2020
The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognitionTakamitsu Hattori, Akiko Koide, Tatyana Panchenko, et al.The Journal of Biological Chemistry|December 7, 2016
A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in MouseNicolin Bloch, Sabine Gläsker, Poojitha Sitaram, et al.Biorxiv : the Preprint Server for Biology|February 10, 2021
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodiesTakuya Tada, Belinda M Dcosta, Marie Samanovic-Golden, et al.Nature Structural & Molecular Biology|April 21, 2004
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genomeQin Yu, Renate König, Satish Pillai, et al.Cell|July 16, 2003
Species-specific exclusion of APOBEC3G from HIV-1 virions by VifRoberto Mariani, Darlene Chen, Bärbel Schröfelbauer, et al.Current Biology : CB|March 11, 2006
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposonsHui Chen, Caroline E Lilley, Qin Yu, et al.Journal of Virology|September 14, 2012
The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleusHenning Hofmann, Eric C Logue, Nicolin Bloch, et al.Virology|February 8, 2003
HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrestIqbal H Chowdhury, Xiao-Fan Wang, Nathaniel R Landau, et al.Pageof 9